The new facility adds capacity for the storage and handling of clinical trial supply materials at controlled room temperatures between 15 - 25 degrees Celsius.
Project will provide a four-fold increase in gene therapy process development and analytical capacity accommodating viral vector, DNA and RNA drug substance.
$2.2 million expansion brings the site’s footprint to 31,000 sq.-ft., creating space for an additional 35 new freezers for ultra-low temperature storage.
R&D facility in Minneapolis expands capacity for small molecule development and manufacturing and expansion in Charles City adds QC lab and office space.